Skip to main content

Henry K. Lui, MD

06/19/2008
Drug-eluting stents (DES) have defined a new era in the successful treatment of coronary artery disease. However, like any therapy, DES results are not always what are predicted or expected. This article outlines strategies for optimizing...
Drug-eluting stents (DES) have defined a new era in the successful treatment of coronary artery disease. However, like any therapy, DES results are not always what are predicted or expected. This article outlines strategies for optimizing...
Drug-eluting stents (DES) have...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Drug-eluting stents (DES) have defined a new era in the successful treatment of coronary artery disease. However, like any therapy, DES results are not always what are predicted or expected. This article outlines strategies for optimizing...
Drug-eluting stents (DES) have defined a new era in the successful treatment of coronary artery disease. However, like any therapy, DES results are not always what are predicted or expected. This article outlines strategies for optimizing...
Drug-eluting stents (DES) have...
06/19/2008
Cath Lab Digest
08/01/2008
Potent inhibition of platelet aggregation during percutaneous coronary intervention (PCI) using intravenous antagonists of the platelet glycoprotein (GP) IIb/IIIa receptor results in a significant and sustained reduction in the occurrence of...
Potent inhibition of platelet aggregation during percutaneous coronary intervention (PCI) using intravenous antagonists of the platelet glycoprotein (GP) IIb/IIIa receptor results in a significant and sustained reduction in the occurrence of...
Potent inhibition of platelet...
08/01/2008
Journal of Invasive Cardiology